Navigation Links
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Date:5/24/2013

or expectations of profit attributable to shareholders; anticipated provisions or write-downs, economic profit, dividends, capital structure or any other financial items or ratios; statements of plans, objectives or goals of Elan, the Elan Group, RP Management or Royalty Pharma following the Increased Offer; statements about the future trends in interest rates, liquidity, foreign exchange rates, stock market levels and demographic trends and any impact that those matters may have on Elan, the Elan Group, RP Management or Royalty Pharma following the Increased Offer; statements concerning any future Irish, US or other economic environment or performance; statements about strategic goals, competition, regulation, regulatory approvals, dispositions and consolidation or technological or regulatory developments; and statements of assumptions underlying such statements.

Forward looking statements only speak as of the date on which they are made, and the events discussed in this announcement may not occur. Subject to compliance with applicable law and regulation, Royalty Pharma is not under any obligation to update publicly or revise forward looking statements, whether as a result of new information, future events or otherwise.

Additional Information

This announcement is not a substitute for the Revised Offer Document and the Revised Acceptance Documents or any other document that Royalty Pharma has filed and may file with the Securities and Exchange Commission ("SEC") (including the Original Offer Document) in connection with the Offer.  ELAN STOCKHOLDERS ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE INCREASED OFFER.  Any such documents will be available free of charge through the website maintained by the SEC at www.sec.gov or by directing a request to any of the persons listed above.

The Offer is and will be m
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
2. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
5. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Pharma Announces Proposal To Acquire Elan
8. Royalty Rates Take Center Stage in Biopharma Dealmaking
9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
10. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
11. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014  Synthetic Biologics, Inc. (NYSE ... drug candidates targeting specific pathogens that cause serious infections ... unusual market activity in the Company,s stock, the NYSE ... with its usual practice. The Company stated that its ... About Synthetic Biologics, Inc. Synthetic ...
(Date:7/29/2014)... New high priced hepatitis C drugs will ... projected $2.9 to $5.8 billion next year, according to ... today by the Pharmaceutical Care Management Association (PCMA). Milliman ... as much as 8.6 percent in 2015 as a ... Olysio. The study finds that the majority ...
(Date:7/29/2014)... 29, 2014 According to a ... Navigation Systems Market (Neurosurgical Navigation Systems, ENT Navigation Systems ... Share, Growth, Trends and Forecast, 2014 - 2020", the ... 218.5 million in 2013 and is expected to grow ... to reach an estimated value of USD 295.5 million ...
Breaking Medicine Technology:Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4
... Oct. 5 The Thompson Group of Companies announced ... (AIT), a Hamilton Sundstrand Corporation business. AIT will ... Group. Financial terms of the purchase were not disclosed. ... manufacture and marketing of process analytical instruments including Analect ...
... CITY, Oct. 5 Orthopedics This Week , a ... Awards for Best New Technology for Spine Care in ... implant and instrument manufacturer focused on unique silicon nitride (SiN) ... in Biomaterials category for its Valeo® AL Lumbar Spacer ...
Cached Medicine Technology:Thompson Group Acquires Hamilton Sundstrand's Applied Instrument Technologies 2Two Amedica®/US Spine® Implant Products Receive Best New Technology Awards from Orthopedics This Week 2
(Date:7/29/2014)... Tampa, Florida (PRWEB) July 29, 2014 More ... Hotel & Casino Tampa will soon be having a complete ... as the place to rock one’s body and soul. , ... salon, which will result in job opportunities for experienced hair ... will be available. Full time team members will be given ...
(Date:7/29/2014)... The Gerontological Society of America (GSA) the ... aging has chosen Corinna E. Lckenhoff, PhD, of ... M. and Paul B. Baltes Foundation Award in Behavioral ... recognizes outstanding early career contributions in behavioral and social ... last ten years are eligible. The award is given ...
(Date:7/29/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... N. Gitlin, PhD, of the Johns Hopkins University Schools ... the M. Powell Lawton Award. , This distinguished ... led to an innovation in gerontological treatment, practice or ... public policy change that has led to some practical ...
(Date:7/29/2014)... Homelands, NY (PRWEB) July 29, 2014 The ... Nation have sent a letter to Washington NFL team owner ... that opposition to the R-word racial slur is emanating from ... the team and Snyder have yet to respond. ... the full text of the letter, which was first ...
(Date:7/29/2014)... 29, 2014 truBrain has created a ... by energy drinks. Think Drinks , available today ... creates optimal conditions for memory, complex reasoning and sustained ... to raise $50,000 over the course of the 30-day ... boost and have compounding effects over time when used ...
Breaking Medicine News(10 mins):Health News:Rock Spa® at Seminole Hard Rock Hotel & Casino Tampa Prepares for Expansion 2Health News:Löckenhoff earns GSA's 2014 Baltes Foundation Award 2Health News:Gitlin earns GSA's 2014 M. Powell Lawton Award 2Health News:Native American Groups Urge Washington Team Owner Dan Snyder to Stop Claiming Name Change Issue Driven by "Elites" Who Are Not People of Color 2Health News:Focus- and Productivity-Enhancing Beverage Launches Crowdfunding Campaign on Indiegogo 2
... A major study published in the November,2007 edition of ... women who completed a study using the Brava System ... full breast size. This key,finding was based on a ... Schlenz, M.D. and Alexandra Kaider, M. Sc. The study ...
... NEW YORK, Oct. 29 The Consumer-Purchaser,Disclosure Project ... employer,organizations working to ensure that all Americans have ... applauds today,s agreement,between the Attorney General of New ... physician performance. This important agreement will,allow physician performance ...
... reminder program, TORONTO, Oct. 29 /PRNewswire/ - Organon ... free telephone-based reminder program designed to,help women remember their ... million women (Stat. Can., 2001) take oral,contraceptives everyday and ... take it at least once. Although the pill is ...
... Key Element To An Effective, Hygiene Protocol. ... WASHINGTON, Oct. 29 The recent outbreak ... as an important,reminder of the importance of routine, ... large number of people constantly live,work or play. ...
... heart despite symptom relief, experts say , , MONDAY, Oct. ... than they did 40 years ago, but not if they ... Mayo Clinic. , "When you look at persons with rheumatoid ... over the last several decades of improved survival the rest ...
... chronic tendinosis of the Achilles tendon can experience a ... of a dextrose solution, according to a recent study ... BC. , Chronic tendinosis is a common overuse injury ... affect many tendons throughout the body, said Norman J. ...
Cached Medicine News:Health News:Newly Published Study in Leading Medical Journal Further Confirms the Brava System's Non-Surgical Breast Enhancement Effectiveness 2Health News:Consumers, Health Care Purchasers Applaud Agreement On Physician Performance Reporting 2Health News:Consumers, Health Care Purchasers Applaud Agreement On Physician Performance Reporting 3Health News:Consumers, Health Care Purchasers Applaud Agreement On Physician Performance Reporting 4Health News:Canada leads the way in contraceptive compliance 2Health News:Canada leads the way in contraceptive compliance 3Health News:Spate of Staph Infections Highlight the Need for Thorough, Consistent Cleaning Regimen at Home, at School and at Work 2Health News:Rheumatoid Arthritis Death Rate Unchanged 2Health News:Rheumatoid Arthritis Death Rate Unchanged 3Health News:Ultrasound-guided injections help ease chronic Achilles tendon pain 2
For primary and revision cases...
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Performa cemented stem....
Medicine Products: